Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Plus Standard BEAM Conditioning for Autologous Hematopoietic Cell Transplantation in Patients With Mature T-Cell Non-Hodgkin Lymphoma: the aTAC BEAM Regimen

NCT02342782 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT02342782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Plus Standard BEAM Conditioning for Autologous Hematopoietic Cell Transplantation in Patients With Mature T-Cell Non-Hodgkin Lymphoma: the aTAC BEAM Regimen
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
June 8, 2020
Completion date
November 18, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mature t-cell and nk-cell non-hodgkin lymphoma, recurrent cutaneous t-cell non-hodgkin lymphoma, recurrent mature t- and nk-cell non-hodgkin lymphoma, refractory cutaneous t-cell non-hodgkin lymphoma, refractory mature t-cell and nk-cell non-hodgkin lymphoma